Masimo (NASDAQ:MASI) Announces Earnings Results

Masimo (NASDAQ:MASI) posted its quarterly earnings data on Tuesday. The medical equipment provider reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.38, Zacks reports. Masimo had a return on equity of 14.98% and a net margin of 3.85%.

Masimo Stock Down 0.7 %

Shares of NASDAQ MASI traded down $1.18 during mid-day trading on Tuesday, reaching $169.54. 687,596 shares of the company’s stock traded hands, compared to its average volume of 484,055. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. Masimo has a 1-year low of $101.61 and a 1-year high of $184.51. The stock has a market cap of $9.08 billion, a P/E ratio of 116.92 and a beta of 1.02. The business has a 50-day simple moving average of $172.65 and a 200 day simple moving average of $152.54.

Analyst Ratings Changes

Several equities analysts have issued reports on MASI shares. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research note on Wednesday, January 22nd. Piper Sandler boosted their target price on shares of Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, December 18th. Wells Fargo & Company raised their price target on shares of Masimo from $171.00 to $193.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. Stifel Nicolaus reiterated a “buy” rating and set a $190.00 price objective (up previously from $170.00) on shares of Masimo in a report on Friday, November 22nd. Finally, Raymond James raised their target price on Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research note on Friday, December 27th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $191.40.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.